Turning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is ...

CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best emerging technology stocks to buy right now. On September 3, Bank of ...

Researchers have developed a new AI tool to help scientists plan gene-editing experiments. "CRISPR-GPT" can help generate ...

Scientists hope genetically modified mice will curb the spread of Lyme disease. They headed to Nantucket — home to a large ...

What you need to know about Ark Invest, an active ETF firm led by Cathie Wood that invests in disruptive, high-growth tech ...

When brain development gets off to a bad start, the consequences are lifelong. One example is a condition called SCN2A ...

Prime Medicine has surged over 130% in three months, driven by pipeline progress and visibility from recent scientific ...

Scientists are hoping to use genetic engineering to reduce the transmission of Lyme disease. The scientists' target is not ...

Researchers unveiled a genetic editing method that uses small nuclear RNAs instead of CRISPR. This approach produced fewer ...

A study using CRISPR restored brain connectivity and made the brain more resilient to seizures, which are often seen in a ...

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $60.62, moving -2.38% from the previous trading session. The stock fell short of the S&P 500, which registered a loss of 0.55% for ...